Minimed GroupMMED +0.14%15 FCF Yield % is 0.97 as of Jun. 27, 2026, which is 194% above its 10-year median of 0.33. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 855 Medical Devices & Instruments companies, Minimed Group ranks better than 59.77% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Minimed Group FCF Yield % Related Terms
Minimed Group FCF Yield % Historical Data
* Premium members only.
The historical data trend for Minimed Group's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minimed Group FCF Yield % Chart
Minimed Group Annual Data
Trend
Apr23
Apr24
Apr25
FCF Yield %
0.00
0.00
0.00
Minimed Group Quarterly Data
Apr24
Jan25
Apr25
Oct25
Jan26
FCF Yield %
0.00
0.00
0.00
0.00
0.00
MMED vs ICUI, WRBY, MMSI: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Minimed Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Minimed Group FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Minimed Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Minimed Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minimed Group (MMED) has a FCF Yield % of 0.97 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Minimed Group and its competitors. This is 194% above median its historical median of 0.33. Over the past decade, Minimed Group's FCF Yield % has ranged from 0.25 to 0.97. According to the industry distribution chart, Minimed Group ranks #344 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 40.2%.
Is Minimed Group's FCF Yield % too high?
Minimed Group's current FCF Yield % of 0.97 is 194% above median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 0.97. Based on the distribution chart, Minimed Group ranks #344 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's FCF Yield % compare to ICUI and WRBY?
According to the Medical Devices & Instruments industry distribution chart, Minimed Group ranks #344 out of 855 companies for FCF Yield %. This puts Minimed Group in the upper half of its industry. Historically, Minimed Group's own FCF Yield % has ranged from 0.25 to 0.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Minimed Group and its competitors. Minimed Group's current FCF Yield % is 0.97, which is 194% above median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current FCF Yield % of 0.97. The current FCF Yield % is 0.97, which is 194% above median its 10-year median of 0.33. Minimed Group's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Minimed Group (MMED), the current FCF Yield % is 0.97 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score
Get the complete analysis for MMED
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MMED has been successfully added to your 